Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

DUBLIN--(BUSINESS WIRE)--The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been added to ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

insulin conjugates with properties such as NNC2215 hold promise for improving treatment of diabetes by potentially lowering the risk of hypoglycemia and partly covering the need for fast-acting ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of Ozempic, Mounjaro soars.

“Ultra-rapid acting insulin is a popular choice for people ... Refer to the User Guide for a list of compatible insulins. WARNING: Control-IQ technology should not be used by anyone under ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

During the 2023 Open Enrollment Period, I discovered that some clients’ insulin would not be covered ... For example, two plans of one insurer list four insulins in their formularies and the ...

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...